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Abstract
Background: Previous study reported that resveratrol has anti-tumor activity. In this study, we
investigated the involvement of autophagy in the resveratrol-induced apoptotic death of human
U251 glioma cells.
Methods: The growth inhibition of U251 cells induced by resveratrol was assessed with methyl
thiazolyl tetrazolium (MTT). The activation of autophagy and proapoptotic effect were
characterized by monodansylcadaverine labeling and Hoechst stain, respectively.
Mitochondrialtransmembrane potential (ΔΨm) was measured as a function of drug treatment using
5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide (JC-1). The role of
autophagy and apoptosis in the resveratrol-induced death of U251 cells was assessed using
autophagic and caspase inhibitors. Immunofluorescence, flow cytometry, and Western blot analysis
were used to study the apoptotic and autophagic mechanisms.
Results: Methyl thiazolyl tetrazolium (MTT) assays indicated that resveratrol decreased the
viability of U251 cells in a dose- and time-dependent manner. Flow cytometry analysis indicated that
resveratrol increased cell population at sub-G1 phase, an index of apoptosis. Furthermore,
resveratrol-induced cell death was associated with a collapse of the mitochondrial membrane
potential. The pan-caspase inhibitor Z-VAD-fmk suppressed resveratrol-induced U251 cell death.
Resveratrol stimulated autophagy was evidenced by punctuate monodansylcadaverine(MDC)
staining and microtubule-associated protein light chain 3 (LC3) immunoreactivty. Resveratrol also
increased protein levels of beclin 1 and membrane form LC3 (LC3-II). Autophagy inhibitors 3-
methylademine (3-MA) and bafilomycin A1 sensitized the cytotoxicity of resveratrol.
Conclusion: Together, these findings indicate that resveratrol induces autophagy in human U251
glioma cells and autophagy suppressed resveratrol-induced apoptosis. This study thus suggests that
autophagy inhibitors can increase the cytotoxicity of resveratrol to glioma cells.
Background
Autophagy is a degradative process involving sequestra-
tion of cytoplasm and organelles into double-membrane
vesicles that traffic the contents to lysosomes where recy-
cling takes place [1-3]. It is a genetically programmed,
evolutionarily conserved process, typically observed in
hepatocytes after amino acid deprivation [4]. Recently,
extensive attention has been paid to the role of autophagy
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ing evidence suggesting that radiation and chemothera-
peutic agents induce autophagy in many human cancer
cell lines [9-11]. In some cases, autophagy is one of the
defensive mechanisms in cancer cells [11-14]. By inducing
autophagy, cancer cells recycle molecules for biosynthetic
or metabolic reactions and subsequently tailoring them-
selves to adverse conditions after anticancer therapy. On
the other hand, persistent activation of autophagy can
also lead to programmed cell death [15,16]. This type of
autophagy is irreversible and is termed as type II pro-
grammed cell death or autophagic cell death, in contrast
to apoptosis, which is referred to type I programmed cell
death [12,17]. The mechanisms by which autophagy dif-
ferentially affects tumor cell survival remain to be uncov-
ered.
Malignant gliomas are the most common primary brain
tumors in the central nervous system. These tumors
increasingly grow and invade into the surrounding brain
parenchyma. Despite advances in surgical preventations
and treatments, the prognosis of this disease remains poor
[18]. Therefore, developing novel strategies are essential
in order to improve effectiveness of treatments for this dis-
ease.
In recent years, many compounds that are contained in
the diet and beverages have been identified as potential
chemopreventive agents. Among them is resveratrol (Res),
a natural product highly enriched in grapes, peanuts, red
wine, and a wide variety of food sources [19]. Its exact
physiological function is still not known, but it has
attracted research attention, owing to its cardioprotective,
antioxidant, anti-inflammatory activities and cancer che-
mopreventive properties [20,21]. Res has a number of
biological effects in a variety of cell culture systems: it pro-
duces variable anti-tumor effects in different tumor cell
lines [19]. Res has been shown to have growth-inhibitory
activity, and induces apoptotic cell death in a number of
human cancer cell lines as well as in animal models of car-
cinogenesis. In U251 glioma cells, treatment with Res led
to growth inhibition, induction of apoptosis and G0/G1-
phase cell cycle arrest [22]. Res also showed antiprolifera-
tive activity in JB6 mouse epidermal, CaCo-2 colorectal
and A431 epidermoid carcinoma cell lines [23-25]. Its
effects in ovarian cancer cell lines are more complicated.
Res can induce ovarian cancer death through two distinct
pathways: apoptosis and autophagy [26]. In the mouse
skin carcinogenesis model, Res inhibited the three major
steps of carcinogenesis: initiation, promotion, and pro-
gression [19]. In human retinoblastoma cells, Res inhibits
cell proliferation and stimulates apoptosis through activa-
tion of the mitochondrial apoptotic pathway [27]. Thus,
multiple mechanisms may be activated by Res, depending
on the specific cell types and cellular environment. How-
ever, the precise role of autophagy in Res's antitumor
effects requires further investigation.
Methods
Chemicals
Res was purchased from Sigma Chemical Co. (St. Louis,
MO, USA) and dissolved in DMSO as a stock solution of
100 mmol/L. The pan-caspase inhibitor Z-VAD-fmk was
obtained from Promega. RPMI-1640 was obtained from
Gibco (Rockville, MD, USA) and fetal bovine serum was
purchased from Hangzhou Sijiqing Biological Engineer-
ing Materials (Hangzhou, China).
Cell Culture
Human glioma U251 cells were purchased from the
Shanghai Institute of Cell Biology, Chinese Academy of
Sciences (Shanghai, China). The cells were maintained in
RPMI-1640 medium supplemented with 10% heat-inacti-
vated fetal bovine serum and 0.03% L-glutamine (Sigma,
St Louis, MO, USA) and incubated in a humidified 5%
CO2 incubator at 37°C. The cells in the mid-log phase
were used in the experiments.
Cell Viability Assay
Cell viability was assessed by MTT assay as described pre-
viously [28]. Cells were plated in 96-well plates at the den-
sity of 10,000 cells in 100 μL medium per well one day
before the experiment. MTT solution was added to the cul-
ture medium (500 μg/ml final concentration) 4 h before
the end of treatments and the reaction was stopped by
addition of 10% acidified SDS (100 μl) to the cell culture.
The absorbance value (A) at 570 nm was read using an
automatic multiwell spectrophotometer (Bio-Rad, Rich-
mond CA, USA). The percentage of cell death (growth
inhibition) was calculated as follows: cell death(%) = (1-
A of experiment well/A of positive control well) ×100%.
Assessment of Mitochondrial Membrane Potential
To measure the mitochondrial membrane potential
(ΔΨm), 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimi-
dazolylcarbocyanine iodide (JC-1), a sensitive fluorescent
probe for ΔΨm was used [29]. The U251 cells were cul-
tured in 24-well plates for 24 h, and then exposed to the
Res (150 μM) for various times. Cells were then rinsed
with PBS twice, stained with 1 mL 10% RPMI-1640
medium containing 5 μmol/L JC-1 (Molecular Probes,
USA) for 30 min at 37°C. Cells were rinsed with ice-cold
PBS twice, resuspended in 1 mL ice-cooled PBS, and
instantly assessed for red and green fluorescence with flow
cytometry (EPICS-XL, Beckman, USA) [30,31]. A 488 nm
filter was used for the excitation of JC-1. Emission filters
of 535 and 595 nm were used to quantify the population
of mitochondria with green (JC-1 monomers) and red(JC-
1 aggregates) fluorescence, respectively [30]. Frequency
plots were prepared for FL1 (green) and FL2 (red) to deter-Page 2 of 9
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(low membrane potential) and red (normal membrane
potential).
Cell cycle analysis
PI staining was used to analyze DNA content. U251 cells
were plated in 10-cm culture dishes at density determined
to yield 60–70% confluence within 24 h. Cells were then
treated, with or without Res 150 μM for 24–48 h, were
trypsinized, stained with PI by the Cellular DNA Flow
Cytometric Analysis Reagent Set (Boehringer Mannheim,
Indianapolis, IN, USA), and analyzed for DNA content
using the FACScan (Becton Dickinson, San Jose, CA, USA)
as previously described [32]. Data were analyzed by Cell
Quest software (Becton Dickinson). All experiments were
performed in duplicate and yielded similar results.
Apoptosis detection assay
To detect apoptosis morphologically, we treated U251
cells with Res for 72 h, fixed them with 4% paraformalde-
hyde, and stained them with Hoechst 33258(0.5 μg/ml)
for 15 min.
Labeling of Autophagic Vacuoles with 
monodansylcadaverine (MDC)
The autofluorescent agent MDC (Sigma) was recently
introduced as a specific autophagolysosome marker to
analyze the autophagic process [33]. U251 cells were
treated with Res 150 μM for 3–24 h. Autophagic vacuoles
were labeled with MDC by incubating cells with 0.05 mM
MDC in RPMI1640 at 37°C for 10 min at various times
after Res treatment. After incubation, cells were washed
three times with PBS and immediately analyzed with a flu-
orescence microscope (Nikon Eclipse TE 300, Japan)
equipped with a filter system (V-2A excitation filter:380/
420 nm, barrier filter:450 nm) [34]. Images were captured
with a CCD camera and imported into Adobe Photoshop.
Immunofluorescence of microtubule-associated protein 
LC3
LC3, a mammalian homologue of Apg8p/Aut7p essential
for amino acid starvation-induced autophagy in yeast
[35], was recruited to the autophagosome membranes in
the Apg5-dependent manner [36]. Therefore, autophago-
some membrane association with LC3 is a specific marker
for autophagy [33]. After being incubated with Res 150
μM for 3–24 h, cells were washed with PBS and then fixed
with paraformaldehyde (4% w:v). After rinsing in PBS, the
cells were blocked with 0.1% Triton X-100 containing 1%
bovine serum albumin in PBS for 1 h. This was followed
by incubation in goat polyclonal antibody against micro-
tubule-associated protein 1 light chain 3 (LC3; 1:100, sc-
16756; Santa Cruz Biotechnology, Santa Cruz, CA, USA)
for 24 h at 4°C in a humidified chamber. After 3 washes
in PBS, the cells were incubated in donkey anti-goat
immunoglobulin G-fluoresceinisothiocyanate (1:400, sc-
2024; Santa Cruz) for 1 h at 4°C. Finally, cells were rinsed
in PBS, coverslipped and examined with a confocal micro-
scope (C1 si, Nikon, Japan).
Western Blot analysis
Whole cell lysates were prepared from treated cells for
Western blot analysis as described previously [37]. Before
immunoblotting, the protein concentrations were deter-
mined with a BCA detection kit (Pierce, USA) and
adjusted to equal concentrations across different samples.
The proteins were separated by 10–12% SDS-PAGE gel
and transferred to nitrocellulose membranes. The mem-
brane was subjected to immunoblotting using enhanced
chemiluminescence (ECL kit; Amersham Pharmacia Bio-
tech, Piscataway, NJ, USA) and visualized by autoradiog-
raphy. Protein β-actin (1:5000; A5441; Sigma) was used
as the loading controls.
Statistical Analysis
All of experiments were repeated at least three times. The
data were presented as means ± SD. Statistical analysis was
carried out by ANOVA followed by a Dunnett t-test, con-
sidering *P < 0.05 as significance. Statistical significance
was assessed using GraphPad Prism 4 software.
Results
Res induces apoptosis of U251 cells
U251 cells were treated with Res at concentrations ranging
from 0 to 300 μM for various lengths of time. The cell via-
bility of U251 cells was determined using the MTT assay.
As shown in Figure. 1, Res reduced U251 cell viability in a
Effects of Res on viability of U251 cellsFigure 1
Effects of Res on viability of U251 cells. U251 cells fol-
lowing exposure to various concentrations of Res at different 
lengths of time and cell viability, analyzed with MTT assay. 
Values were given as mean ± SD; *, p < 0.05 vs control (n = 
6).Page 3 of 9
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ment, the inhibitory rate of Res (150 μM) on viability of
U251 cells had reached 51.29 ± 0.64%, and when the
incubation time was prolonged to 72 h, the inhibitory rate
increased to 62.56 ± 0.36%. While at the dose of 75 μM
the inhibitory ratio was 41.03 ± 0.32% with 48 h of treat-
ment. Based on this dose-effect relationship, Res concen-
tration of 150 μM was used for subsequent studies.
To examine whether Res affects cell cycle and induces
apoptosis, we performed the DNA flow cytometric analy-
sis. As shown in Figure. 2, cells treated with Res (150 μM)
for 48 h showed increased population of cells in sub-G1
phase, characteristic of apoptosis, from 4.04 ± 0.46% to
11.82 ± 1.30%.
To determine the incidence of apoptosis morphologically,
we stained the nuclei of treated U251 cells with Hoechst
33258. As shown in Figure. 3, apoptotic morphological
characteristics such as chromatin condensation and
nuclear fragmentation were detected in U251 cells treated
with Res.
It has been suggested that Res-induced apoptotic death
may be mediated by mitochondria-dependent signaling
pathways [22]. Chemically promoted apoptosis mediated
by the mitochondria/caspase-9 activation pathway is
often, though not always, associated with the collapse of
ΔΨm as a result of leakiness of the inner mitochondrial
membrane [38]. Therefore, to investigate whether mito-
chondrial membrane integrity is damaged by Res, mito-
chondrial membrane potential was measured using JC-1,
a sensitive fluorescent probe for ΔΨm [29].
U251 cells were cultured in 24-well plates and treated
with Res for various lengths of time. When ΔΨm was low,
JC-1 existed mainly in a monomeric form, which emits
green fluorescence. As shown in Figure. 4, an increase in
the amount of mitochondria with collapsed membrane
potential was detected as early as 6 h after Res treatment.
To make a quantitative analysis, we use a flow cytometer
(EPICS-XL, Beckman, USA). As shown in the Figure. 5, the
DNA flow-cytometric analysis of U251 cells after treatment with ResFigure 2
DNA flow-cytometric analysis of U251 cells after 
treatment with Res. The cells at the sub-G1 fraction were 
determined by DNA flow-cytometric analysis. Differences 
between control, UNT and 150 μM of Res treatment for 24 
h or 48 h were observed; *, p < 0.001 (n = 6); data are pre-
sented as means ± SD.
Hoechst 33258 stainingFigure 3
Hoechst 33258 staining. Nuclei of U251 cells were 
treated with Res (150 μM) for 72 h and stained with Hoechst 
33258 to detect apoptosis morphologically. Microphoto-
graphs were shown as representative results from three 
independent experiments. ×400. Bar, 50 μm.
Collapse of mitochondrial ΔΨm induced by ResFigure 4
Collapse of mitochondrial ΔΨm induced by Res. U251 
cells were cultured and incubated with Res (150 μM) for 6–
72 h. Cells were stained with JC-1 and examined with fluo-
rescence microscopy. Cells with normal mitochondria pre-
dominantly show red fluorescence. Cells with decreased 
mitochondrial membrane potential emit diffuse green fluo-
rescence in the cytoplasm. Microphotographs were shown as 
representative results from three independent experiments. 
×400.Page 4 of 9
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after Res treatment. This alteration reached its peak 72 h
after Res treatment. These results indicate that a dysfunc-
tion of ΔΨm is an early event in Res-induced cell death.
To confirm an apoptotic mechanism in Res-induced death
of U251 cells, the effects of pretreatment with the pan-cas-
pase inhibitor Z-VAD-fmk were investigated. U251 cells
were pretreated with Z-VAD-fmk 1 h before Res treatment,
cell viability was determined with MTT assay 48 h later. As
shown in Figure. 6, Z-VAD-fmk significantly inhibited the
cytotoxicity of Res.
Res activates autophagy in U251 cells
As Res-treated U251 cells triggered a slow process of apop-
tosis, we next assessed whether Res induces autophagy in
U251 cells. MDC accumulates in mature autophagic vac-
uoles, such as autophagolysosomes, but not in the early
endosome compartment [33]. MDC staining can be used
to detect autophagic vacuoles. When cells are viewed with
a fluorescence microscope, AVs stained by MDC appear as
distinct dot-like structures distributed within the cyto-
plasm or localizing in the perinuclear regions. As shown
in Figure. 7, there was an increase in the number of MDC-
labeled vesicles at 24 h after Res treatment. The result indi-
cates an induction of AV formation by Res.
LC3 is localized in autophagosome membranes during
amino acid starvation-induced autophagy [35,36]. LC3 is
considered a molecular marker of autophagosomes. To
assess if LC3 is altered in Res-induced autophagy, we
examined localization of LC3 immunoreactivity. Under a
fluorescence microscope, punctate patterns of LC3 immu-
noreactivity in many cells were observed after Res (150
μM) treatment, representing increased formation of
autophagic vacuoles (Figure. 8). In contrast, the control
cells only showed diffuse distribution of LC3 immunore-
activity.
Recent investigations suggest that there are two forms of
the LC3 proteins in various cells: LC3-I and LC3-II [36].
Effects of Res on alterations in mitochondria membrane potentialFigure 5
Effects of Res on alterations in mitochondria mem-
brane potential. U251 cells were treated with Res (150 
μM) for various lengths of time. Mean percentage of U251 
cells stained green (FL 1-H) of all total cells was determined 
by flow cytometry. Results (mean ± SD) from 3 independent 
experiments were quantitatively analyzed. *, P < 0.05 com-
pared to the control group.
Effect of Res on induction of apoptosisFigure 6
Effect of Res on induction of apoptosis. Effects of cas-
pase inhibitors on Res-induced death of U251 cells. U251 
cells were pretreated with Z-VAD-FMK 1 h before Res (150 
μM). Cell viability was determined by MTT assay 48 h later. 
Data are presented as means; bars, ± SD.(n = 3). *, p < 0.05 
compared to control group; #, p < 0.05 compared to Res 
alone within the treated group.
MDC-labeled vesicles were induced after Res treatmentFigure 7
MDC-labeled vesicles were induced after Res treat-
ment. U251 cells were incubated with Res(150 μM) for the 
indicated time and stained with MDC(50 μM). Fluorescence 
particles in the cytoplasm indicate autophagic vacuoles. 
Microphotographs were shown as representative results 
from 3 independent experiments. Magnification ×400. Bar, 50 
μm.Page 5 of 9
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II, which is autophagosome membrane bound. Therefore,
the amount of LC3-II is correlated with the extent of
autophagosome formation. Using Western Blot analysis
with anti-LC3 antibody, we examined the expressions of
LC3-I (18 kDa) and LC3-II (16 kDa) in U251 cells after
treatment with Res (150 μM). As seen in Figure. 9, an
apparent increase in the levels of LC3-II protein was
detected in U251 cells 24 h after treatment with Res, with
a peak effect occurred at 48 h.
Autophagy is controlled by a group of evolutionarily con-
served genes (ATG genes) [39,40]. More than 30 ATG
genes have been identified in yeast and at least 11 have
orthologs in mammals, Atg6 is known as beclin1. Beclin
1/Atg6 is a part of type III PI3 kinase complex that is
required for the formation of the autophagic vesicle and
interference with beclin 1 can prevent autophagy induc-
tion. Therefore, beclin 1 plays considerable roles in the
processes of autophagy. The Western blot analysis
revealed that beclin 1 levels were markedly increased 3 h
after Res treatment, but decreased dramatically 24 h later
(Figure. 10).
Autophagy reduces Res-induced death of U251 cells
3-MA, the specific class III PI3 kinase inhibitor, prevents
autophagy at an early stage; while bafilomycin A1, a spe-
cific inhibitor of vacuolar H+-ATPase, prevents autophagy
at a late stage by inhibiting fusion between autophago-
somes and lysosomes. To investigate the effects of
autophagy on Res-induced apoptosis, 3-MA was added 1
h before Res. Results showed that 3-MA alone had little
effect on sub-G1 fraction, an indicator of apoptotic cell
death; however, pretreatment of U251 cells with 3-MA sig-
nificantly increased the sub-G1 fraction induced by Res
(Figure. 11).
In addition, to explore inhibition of autophagy at a late
stage, bafilomycin A1 was added before Res. As shown in
Figure. 12, the specific inhibitor of vacuolar H+-ATPase
bafilomycin A1 alone had no significant effect in U251
cells, however, Res-induced cytotoxicity was significantly
potentiated by bafilomycin A1.
Discussion
compounds used in cancer chemotherapy are derived
from plant sources. Among them is hydroxylated stilbene
LC3 immunofluorescence in U251 cells after Res treatmentFigure 8
LC3 immunofluorescence in U251 cells after Res 
treatment. U251 cells were incubated with Res(150 μM) 
for the indicated time and stained with anti-LC3 antibody. 
Cells were examined by fluorescence confocal microscopy. 
Magnification ×400. Bar, 50 μm.
LC3 protein expression in U251 cellsFigure 9
LC3 protein expression in U251 cells. Western blot 
analysis of LC3 expression after 3, 6, 12, 24, and 48 h of 
treatment with 150 μM of Res. **, P < 0.05 compared to the 
control group.
Beclin-1 protein expression in U251 cellsFigure 10
Beclin-1 protein expression in U251 cells. Western blot 
analysis of beclin-1 expression after 3, 6, 12, 24, 48, and 72 h 
of treatment with 150 μM of Res. **, P < 0.05 compared to 
the control group.Page 6 of 9
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such as grapes, peanuts, berries and wine [41]. Previous
study indentified the cancer chemopreventive activity of
Res, which inhibits cellular events associated with tumor
initiation, promotion and progression, more consistent
with the actions of conventional chemotherapeutic
drugs[] veratrol induces growth inhibition, S-phase arrest,
apoptosis, and changes in biosion in several human can-
cer cell lines [42]. It has been shown that Res affects many
different signal pathways in many types of cells. However,
except for some preliminary reports, there is little experi-
mental evidence supporting its efficacy in treating tumor
cells or malignancies in animals [43,44]. Malignant glio-
mas are the primary brain tumor among many tumors.
Previous study described that resveratrol induced apop-
totic death in human U251 glioma cells [22]. In this
study, we observed dose- and time-dependent cytotoxic
effects of Res against U251 cells. These results are consist-
ent with other reports showing the cytotoxic effects of Res
to tumor cells [25,42].
Our present study suggests that Res induces autophagy in
human U251 glioma cells. It was found that after Res
treatment, vacuoles labeled by MDC increased in the cyto-
plasm. We also observed green punctate immunostaining
of LC3 scattered in the cytoplasm. It has been demon-
strated recently that LC3 is the first mammalian protein
that is specifically recruited to autophagosome mem-
branes [35]. These findings are similar to those showing
autophagy activation after amino acid deprivation.
Whether autophagy promotes cell death or inhibits cell
death is circumstantial. Some studies suggested that
autophagy is a cell death mechanism. Autophagy is
referred to as programmed cell death type II, while apop-
tosis is well known as programmed cell death type I
[45,46]. Cells undergoing autophagic cell death or apop-
tosis display distinct morphological features. In apopto-
sis, there is condensation and fragmentation of DNA but
preservation of organelles until late in the process. In con-
trast, in autophagic, or programmed cell death type II,
there is early degradation of organelles whereas preserva-
tion of nucleus until late stages [47]. On the other hand,
autophagy may serve as a key mechanism of cell sur-
vival[48]. This function of autophagy is an evolutionarily
ancient process, conserved from yeast to mammals, and
best characterized in nutrient deficiency. Autophagy can
protect cells by inhibiting them from undergoing apopto-
sis[49]. In our study, inhibition of autophagy with 3-MA
significantly increased the sub-G1 fraction and subse-
quently promoted U251 cells to cell death. Another spe-
cific inhibitor of the lysosomal protein pump ATP,
bafilomycin A1, also increased Res-induced cytotoxicity.
These findings suggest that autophagy plays an important
role in Res-induced cell death and that inhibition of
autophagy significantly affects the anti-tumor effects of
Res. Autophagy may play an inhibitory role in the apop-
totic process in U251 cell after treatment with Res. There-
fore, agents that inhibit autophagy may be potential
candidates to combine with Res for anti-tumor treatment.
Cell death is often associated with the collapse of ΔΨm
[50]. The mitochondrion may integrate cell death signals
Effects of 3-MA on Res-induced death of U251 cellsFigure 11
Effects of 3-MA on Res-induced death of U251 cells. 
U251 cells were pretreated with various doses of bafilomycin 
A1 1 h before Res (150 μM). The appearance of sub-G1 frac-
tion was determined by DNA flow-cytometric analysis. Dif-
ferences between control, Res (150 μM) and 3-MA (10 
mM)+Res (150 μM) treatment for 24 or 48 h were observed. 
Data are presented as means ± SD (n = 6). *, p < 0.001 com-
pared to control group; #, p < 0.001 compared to Res alone 
group.
Effects of bafilomycin A1 on Res-induced death of U251 cellsFigure 12
Effects of bafilomycin A1 on Res-induced death of 
U251 cells. U251 cells were pretreated with various doses 
of bafilomycin A1 1 h before Res (150 μM). Cell viability was 
evaluated by MTT assay 24 and 48 h later. Data are pre-
sented as means ± SD (n = 3). *, p < 0.05 compared to con-
trol group; #, p < 0.05 compared to Res alone group.Page 7 of 9
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apoptosis and autophagic cell death are interconnected
through mitochondrial permeability transition(MPT)
[51]. It has been shown that Res-induced apoptosis
requires the activation of caspase-3 and increased release
of cytochrome c. Accordingly, we observed a rapid
decrease in ΔΨm after resveratrol treatment at an early
stage. As a result, the loss of mitochondrial membrane
polarization seem to be a intracellular signal that may be
responsible for the induction of autophagy and apoptosis.
Thus, the relationship among MPT, apoptosis and
autophagy remains unclear, which requires further inves-
tigation.
Conclusion
In summary, this study showed that Res induces
autophagy in human U251 glioma cells. Autophagy and
apoptosis play different roles in Res-induced death of
U251 cells. Apoptosis is an important cause of death of
U251 cells, while autophagy delays apoptosis and protect
cells from death. These findings add a novel concept to
Res-induced cell death pathways and suggest that
autophagy inhibitors may be potential agents to enhance
Res's anti-tumor efficacy.
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